연구동향 분석

Identification of novel biomarker for early detection of diabetic nephropathy

Kim, Kyeongseok 2020년

논문상세정보
인용/피인용
' Identification of novel biomarker for early detection of diabetic nephropathy' 의 주제별 논문영향력
논문영향력 선정 방법
논문영향력 요약
주제
  • Diabetic nephropathy
  • RNA Sequencing
  • biomarker
동일주제 총논문수 논문피인용 총횟수 주제별 논문영향력의 평균
291 0

0.0%

' Identification of novel biomarker for early detection of diabetic nephropathy' 의 참고문헌

  • and T. Vilsb©ªll . 2016 . Semaglutide and Cardiovascular Outcomes
    Diabetes . N Engl J
  • What are biomarkers ?
    5 ( 6 ) :463-6 [2010]
  • Wang, T., R. Zhou, L. Gao, Y. Wang, C. Song, Y. Gong, J. Jia, W. Xiong, L. Dai, L. Zhang, and H. Hu. 2014. Elevation of urinary adipsin in preeclampsia: correlation with urine protein concentration and the potential use for a rapid diagnostic test. Hypertension 64 (4):846-51.
  • Wan, E. Y. F., D. Y. T. Fong, C. S. C. Fung, E. Y. T. Yu, W. Y. Chin, A. K. C. Chan, and C. L. K. Lam. 2017. Prediction of five-year all-cause mortality in Chinese patients with type 2 diabetes mellitus - A population-based retrospective cohort study. J Diabetes Complications 31 (6):939-944.
  • Volanakis, J. E., S. R. Barnum, M. Giddens, and J. H. Galla. 1985. Renal filtration and catabolism of complement protein D. N Engl J Med 312 (7):395-9.
    312 ( 7 ) :395-9 [1985]
  • Use of molecular biomarkers for predicting the response to radiotherapy with or without chemotherapy .
    25 ( 26 ) :4075-83 [2007]
  • Urinary Cyclophilin A as a New Marker for Diabetic Nephropathy : A Cross-Sectional Analysis of Diabetes Mellitus
    94 ( 42 ) : e1802 . [2015]
  • Trends in the epidemiology and care of diabetes mellitus-related end-stage renal disease in France
    57 ( 4 ) :718-28 . [2014]
  • The worldwide epidemiology of type 2 diabetes mellitus -present and future perspectives
    8 ( 4 ) :228-36 [2011]
  • The role of the complement system in diabetic nephropathy
    13 ( 5 ) :311-318 [2017]
  • The role of inflammatory cytokines in diabetic nephropathy
    19 ( 3 ) :433-42 [2008]
  • The chemokine receptor CXCR6 contributes to recruitment of bone marrow-derived fibroblast precursors in renal fibrosis
    86 ( 2 ) :327-37 . [2014]
  • TGF beta 2 , LIF and FGF2 cooperate to induce nephrogenesis
    128 ( 7 ) :1045-57 . [2001]
  • Strategies for analysis of the glycosylation of proteins : current status and future perspectives
    43 ( 1 ) :76-88 [2009]
  • Saftig , S. Rose-John , and A. Ludwig . 2004 . The transmembraneCXC-chemokine ligand 16 is induced by IFN-gamma and TNF-alpha
    by the activity of the disintegrin-like
  • STRL33 , A novel chemokine receptor-like protein , functions as a fusion cofactor for both macrophage-tropic and T cell line-tropic HIV-1
    185 ( 11 ) :2015-23 . [1997]
  • Role ofComplement andComplement regulatory proteins in theComplications of diabetes
    36 ( 3 ) :272-88 [2015]
  • Role forCXCR6 in recruitment of activatedCD8+ lymphocytes to inflamed liver
    174 ( 1 ) :277-83 . [2005]
  • RNA-seq data of invasive ductalCarcinoma and adjacent normal tissues from a Korean patient with breastCancer
    [2018]
  • RNA sequencing ( RNA-Seq ) and its application in ovarianCancer
    152 ( 1 ) :194-201 . [2019]
  • Qin, X., A. Goldfine, N. Krumrei, L. Grubissich, J. Acosta, M. Chorev, A. P. Hays, and J. A. Halperin. 2004. Glycation inactivation of the complement regulatory protein CD59: a possible role in the pathogenesis of the vascular complications of human diabetes. Diabetes 53 (10):2653-61.
  • Proteomic analysis of urinary protein markers for accurate prediction of diabetic kidney disorder
    [2005]
  • Protective effects of leukemia inhibitory factor against oxidative stress during high glucose-induced apoptosis in podocytes
    17 ( 4 ) :485-93 . [2012]
  • Prevention ofCrescentic glomerulonephritis by immunoneutralization of the fractalkine receptorCX3CR1 rapidCommunication
    56 ( 2 ) :612-20 . [1999]
  • Podocytes : the Weakest Link in Diabetic Kidney Disease ?
    16 ( 5 ) :45 . [2016]
  • Percentage of circulating CD8+ T lymphocytes is associated with albuminuria in type 2 diabetes mellitus
    122 ( 1 ) :27-30 . [2014]
  • Peng, B., L. Zhang, J. Yan, H. Qi, W. Zhang, L. Fan, Y. Hu, L. Lin, X. Li, R. Hu, L. Xie, J. Zhang, Y. Wu, L. Li, and R. Zhou. 2017. Assessment of the diagnostic value of a urinary adipsin rapid strip test for pre-eclampsia: A prospective multicenter study. J Obstet Gynaecol Res 43 (1):30-33.
  • Pathogenesis of diabetic nephropathy
    2 ( 4 ) :243-247 . [2011]
  • Omics-based molecular target and biomarker identification
    [2011]
  • Novel fusion transcripts in bladder cancer identified by RNA-seq .
    374 ( 2 ) :224-8 . [2016]
  • Normoalbuminuric renal-insufficient diabetic patients : a lower-risk group .
    30 ( 8 ) :2034-9 . [2007]
  • Normalizing mitochondrial superoxide production blocks three pathways of hyperglycaemic damage
    404 ( 6779 ) :787-90 [2000]
  • Morphology of the pancreas in type 2 diabetes : effect of weight loss with or without normalisation of insulin secretory capacity
    59 ( 8 ) :1753-9 . [2016]
  • Molecular basis for a link between complement and the vascular complications of diabetes
    97 ( 10 ) :5450-5 . [2000]
  • Molecular and functional identification and purification of complement component factor D from urine of patients with chronic renal failure
    27 ( 7 ) :637-44 [1990]
  • MicroRNAs : novel regulators in the hallmarks of human cancer
    285 ( 2 ) :116-26 . [2009]
  • Metabolomics in biomarker discovery : future uses for cancer prevention
    4 ( 1 ) :93-102 [2008]
  • Metabolism of complement factor D in renal failure
    34 ( 4 ) :529-36 [1988]
  • Mechanisms of Podocyte Injury in Diabetes
    58 ( 5 ) :1201 . [2009]
  • Measuring reactive species and oxidative damage in vivo and in cell culture : how should you do it and what do the results mean ?
    142 ( 2 ) :231-55 [2004]
  • Long, L., H. Qiu, B. Cai, N. Chen, X. Lu, S. Zheng, X. Ye, and Y. Li. 2018. Hyperglycemia induced testicular damage in type 2 diabetes mellitus rats exhibiting microcirculation impairments associated with vascular endothelial growth factor decreased via PI3K/Akt pathway. Oncotarget 9 (4):5321-5336.
  • Leukemia Inhibitory Factor Is Involved in Tubular Regeneration after Experimental Acute Renal Failure
    14 ( 12 ) :3090-3101 . [2003]
  • Lee, Y. K., E. Y. Park, S. Kim, J. Y. Son, T. H. Kim, W. G. Kang, T. C. Jeong, K. B. Kim, S. J. Kwack, J. Lee, S. Kim, B. M. Lee, and H. S. Kim. 2014. Evaluation of cadmium-induced nephrotoxicity using urinary metabolomic profiles in sprague-dawley male rats. J Toxicol Environ Health A 77 (22-24):1384-98.
  • Kidney Disease Caused by Dysregulation of the Complement Alternative Pathway : An Etiologic Approach
    26 ( 12 ) :2917-2929 [2015]
  • Karbach, S., T. Jansen, S. Horke, T. Heeren, A. Scholz, M. Coldewey, A. Karpi, M. Hausding, S. Kroller-Schon, M. Oelze, T. Munzel, and A. Daiber. 2012. Hyperglycemia and oxidative stress in cultured endothelial cells--a comparison of primary endothelial cells with an immortalized endothelial cell line. J Diabetes Complications 26 (3):155-62.
  • Intravascular Immune Surveillance by CXCR6+ NKT Cells Patrolling Liver Sinusoids
    3 ( 4 ) : e113 . [2005]
  • Intercellular adhesion molecule-1 deficiency is protective against nephropathy in type 2 diabetic db/db mice
    16 ( 6 ) :1711-22 [2005]
  • Inflammation-activated CXCL16 pathway contributes to tubulointerstitial injury in mouse diabetic nephropathy
    39 ( 6 ) :1022-1033 . [2018]
  • Incidence of renal replacement therapy for diabetic nephropathy in the Netherlands : Dutch diabetes estimates ( DUDE ) -3
    5 ( 1 ) : e005624 . [2015]
  • Immunoinflammation in diabetic nephropathy : molecular mechanisms and therapeutic options.127-146
    [2012]
  • Identification of noninvasive biomarkers for nephrotoxicity using HK-2 human kidney epithelial cells .
    140 ( 2 ) :247-58 . [2014]
  • Identification of annexin II as a novel secretory biomarker for breast cancer
    13 ( 21 ) :3145-56 . [2013]
  • Identification of ROS using oxidized DCFDA and flow-cytometry
    [2010]
  • Hyperglycemia and mechanical stress : targeting the renal podocyte
    221 ( 2 ) :288-95 . [2009]
  • How much glycemic control is needed to prevent progression of diabetic nephropathy ?
    3 ( 5 ) :411-412 [2012]
  • Glycemic management in ESRD and earlier stages of CKD
    63 ( 2 Suppl 2 ) : S22-38 [2014]
  • Genomic and proteomic biomarkers for cancer : a multitude of opportunities
    1796 ( 2 ) :176-93 . [2009]
  • Gene Ontology and KEGG Pathway Enrichment Analysis of a Drug Target-Based Classification System
    10 ( 5 ) : e0126492 . [2015]
  • From hyperglycemia to diabetic kidney disease : the role of metabolic , hemodynamic , intracellular factors and growth factors/cytokines
    25 ( 6 ) :971-1010 . [2004]
  • Feng . 1998 . In vivo inhibition of CC and CX3C chemokine-induced leukocyte infiltration and attenuation of glomerulonephritis in Wistar-Kyoto ( WKY )
    . J Exp Med 188 (
  • Expression of the novel scavenger receptor SR-PSOX in cultured aortic smooth muscle cells and umbilical endothelial cells
    22 ( 4 ) :710-1 [2002]
  • Expression of CXCL16 in human T cells
    23 ( 1 ) :148-9 . [2003]
  • Expression cloning of the STRL33/BONZO/TYMSTRligand reveals elements of CC , CXC , and CX3C chemokines
    166 ( 8 ) :5145-54 . [2001]
  • Expression and coreceptor activity of STRL33/Bonzo on primary peripheral blood lymphocytes
    96 ( 1 ) :41-9 . [2000]
  • Evaluation of the proteolytic activity of factor D accumulated as an active serine protease in patients with chronic renal failure
    66 ( 3 ) :285-90 [1994]
  • Epidemiology of diabetes and diabetes-related complications
    88 ( 11 ) :1254-64 . [2008]
  • Differences in microRNA detection levels are technology and sequence dependent
    19 ( 4 ) :527-38 . [2013]
  • Diabetic Nephropathy : The Proteinuria Hypothesis
    25 ( 2 ) :77-94 . [2005]
  • Diabetes and end-stage renal disease ; a review article on new concepts
    4 ( 2 ) :28-33 . [2015]
  • DNA methylation as a biomarker in breast cancer
    5 ( 8 ) :1245-56 . [2009]
  • Complement and the kidney : What the nephrologist needs to know in 2006 ?
    20 ( 12 ) :2613-2619 . [2005]
  • Complement and kidney disease
    22 ( 3 ) :295-301 [2013]
  • Complement : a key system for immune surveillance and homeostasis
    11 ( 9 ) :785-97 . [2010]
  • Comparison of RNA-Seq and Microarray Gene Expression Platforms for the Toxicogenomic Evaluation of Liver From Short-Term Rat Toxicity Studies
    9 ( 636 ) . [2019]
  • Comparative study of de novo assembly and genome-guided assembly strategies for transcriptome reconstruction based on RNA-Seq
    56 ( 2 ) :143-55 [2013]
  • Clinical significance of inflammatory and fibrogenic cytokines in diabetic nephropathy
    45 ( 9 ) :646-50 . [2012]
  • Chemokines and renal disease
    26 ( 6 ) :982-94 . [1995]
  • Chemokine regulation of normal and pathologic immune responses
    19 ( 5 ) :388-96 . [2001]
  • Cancer . Developing molecular biomarkers for cancer
    299 ( 5613 ) :1679-80 . [2003]
  • CXCL16 signals via Gi , phosphatidylinositol 3-kinase , Akt , I kappa B kinase , and nuclear factor-kappa B and induces cell-cell adhesion and aortic smooth muscle cell proliferation
    279 ( 5 ) :3188-96 . [2004]
  • Biomarkers of nephrotoxic acute kidney injury
    245 ( 3 ) :182-93 . [2008]
  • Beyond lysis : how complement influences cell fate
    104 ( 5 ) :455-66 . [2003]
  • Advanced glycation end products and diabetic complications
    18 ( 1 ) :1-14 [2014]
  • A transmembrane CXC chemokine is a ligand for HIV-coreceptor Bonzo .
    1 ( 4 ) :298-304 . [2000]
  • , and J . B. Buse . 2016
    in Type 2 Diabetes . N